Dear Pharma Aspirants,
Drug Safety Alert PVPI November 2023 – Monthly Drug Safety Alert
Healthcare Professionals, Patients/Consumers are advised to closely monitor the possibility
of the above ADR associated with the use of above suspected drug. If, such reaction is
encountered, please report to the NCC-PvPI, IPC by filling of Suspected Adverse Drug
Reactions Reporting Form/Medicines Side Effect Reporting Form for Consumer
(http://www.ipc.gov.in), through Android Mobile App “ADR PvPI” and PvPI Helpline No.
1800-180-3024.
Suspected Drug : Mefenamic Acid
Indication: Treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhoea, mild to moderate pain, inflammation, fever, dental pain.
Adverse Drug Reaction: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
ALSO READ: New Label Warning for FDC of Chlorpheniramine Maleate
For More Updates Join our group: Click Here
